M J Rybak Selected Research

Therapeutics

1/2017	Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.
8/2001	Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and review.
4/2001	Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria.
7/2000	Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M J Rybak Research Topics

Disease

17	Infections 11/2019 - 03/2000
4	Endocarditis 01/2017 - 07/2000
2	Soft Tissue Infections 03/2006 - 03/2001
2	Body Weight (Weight, Body) 11/2000 - 07/2000
1	Coinfection 01/2017
1	Gram-Positive Bacterial Infections 03/2006
1	Communicable Diseases (Infectious Diseases) 04/2001
1	Bacteremia 02/2001
1	Bacterial Endocarditis 07/2000

Drug/Important Bio-Agent (IBA)

7	Daptomycin FDA Link 01/2017 - 07/2000
6	Vancomycin FDA LinkGeneric 11/2019 - 07/2000
5	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017 - 07/2000
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2006 - 07/2000
3	AminoglycosidesIBA 04/2001 - 07/2000
2	oritavancinIBA 12/2001 - 11/2000
2	Linezolid (Zyvox)FDA Link 12/2001 - 03/2001
2	Levofloxacin (Levaquin)FDA Link 08/2001 - 03/2000
2	Penicillins (Penicillin)FDA Link 04/2001 - 03/2000
2	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 02/2001 - 05/2000
2	GlycopeptidesIBA 11/2000 - 07/2000
2	FibrinIBA 07/2000 - 03/2000
2	trovafloxacinIBA 05/2000 - 03/2000
1	Ceftaroline FDA Link 11/2019
1	alpha,beta-diacryloxypropionic acid (DAPS)IBA 01/2017
1	LipopeptidesIBA 03/2006
1	FluoroquinolonesIBA 08/2001
1	beta-LactamsIBA 04/2001
1	Methicillin (Metin)FDA Link 04/2001
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 02/2001
1	triphenylmethylphosphoniumIBA 08/2000
1	Proteins (Proteins, Gene)FDA Link 08/2000
1	Anti-Infective Agents (Microbicides)IBA 07/2000
1	arbekacinIBA 07/2000
1	Ampicillin (Omnipen)FDA LinkGeneric 07/2000
1	CreatinineIBA 05/2000
1	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2000
1	sparfloxacin (AT 4140)FDA Link 03/2000
1	Gatifloxacin (Zymar)FDA Link 03/2000
1	clinafloxacinIBA 03/2000

Therapy/Procedure

4	Therapeutics 01/2017 - 07/2000
3	Length of Stay 11/2019 - 02/2001
1	Transplantation 10/2012
1	Heart-Assist Devices 10/2012
1	Drug Therapy (Chemotherapy) 04/2001
1	Contraindications 09/2000